Tag: CPAP Device
Purchase mix will shift when Philips re-enters market, survey findsÂ
September 18, 2023HME News Staff
NEW YORK – ResMed will likely lose CPAP device market share when Philips re-enters the market, according to the 3Q23 HME Sleep and Oxygen Survey from Needham.
Respondents to the survey indicated that if Philips re-entered the market and had unconstrained supply, they would return to purchasing 26% of their pre-recall CPAP device volume from Philips, though that’s down from 32% in a prior survey.
Additionally, when Philips re-enters the market, 8% of respondents...
ResMed revenue buoyed by ramped up productionÂ
April 27, 2023HME News Staff
SAN DIEGO – ResMed reported revenue increased 29% to $1.1 billion and net income increased 30% to $232.5 million in the third quarter of fiscal year 2023.
It reported gross margin contracted 150 bps to 55.3% and non-GAAP GM contracted 200 bps to 56.1%, driven primarily by unfavorable product mix and higher component costs, partially offset by an increase in average selling prices.
“During the third quarter, we significantly ramped up production and delivery of our cloud-connected...
OxyGo launches sleep lineÂ
November 28, 2022HME News Staff
ORLANDO, Fla. – OxyGo, a supplier of portable oxygen concentrators, has launched a new sleep line. OxyGo SLEEP offers a full line of products, including CPAP and BPAP devices, travel batteries, sanitizers and accessories, as well as a web-based compliance portal for managing patient devices. “Launching a portal that will allow providers to communicate stats and share data with other health care professionals is key to making the user experience better for both sleep providers and patients,”...
CPAP providers: Could that be a light at the end of the tunnel?
September 23, 2022Theresa Flaherty, Managing Editor
YARMOUTH, Maine – CPAP providers are seeing a slow rebound in business as a chokehold on orders for devices eases up, but they continue to see increased costs.
For more than a year, providers have juggled the challenges of a recall of certain CPAP devices by Philips and a subsequent shortage of available devices on the market with overall supply chain challenges affecting all manufacturers.
“Looking at my numbers from April to August, we’ve set up more CPAPs during...
CPAP trumps MAD in certain parameters, study finds
August 23, 2022HME News Staff
YARMOUTH, Maine – Treatment with CPAP devices was better than mandibular advancement devices at normalizing polysomnographic parameters and improving quality of life in patients with mild obstructive sleep apnea, according to a recent study published in Sleep Breathing Physiology and Disorders. Fatigue was improved in both CPAP and MAD groups, and daytime sleepiness, mood and sustained attention showed no difference. This study was a single-blind, parallel, randomized clinical trial with controls....
Philips recall: FDA continues review of medical device reportsÂ
August 22, 2022HME News Staff
WASHINGTON – The U.S. Food and Drug Administration updated its safety communication for the Philips recall this month, saying it received more than 48,000 medical device reports, including 44 reports of death, associated with the foam breakdown or suspected foam breakdown in certain CPAP devices from May 1, 2022, through July 31, 2022.
The agency previously reported in May that it received more than 21,000 MDRs, including 124 reports of death, associated with the foam breakdown...
SleepRes hires former Philips engineerÂ
July 22, 2022HME News Staff
NASHVILLE, Tenn. - SleepRes, developer of the V̇-Com, has announced Bernard Hete, PhD, as its chief technology officer to oversee future research and development. He was a senior engineer at Philips Respironics for 30 years. “Bernie [Dr. Hete] was always the smartest guy in the room, who always kept our ideas at Respironics to the laws of physics,” said Eugene Scarberry, a retired senior engineer at Philips who got the first FDA approval for CPAP back in 1985. “I have known...
ResMed: ‘Our third-quarter results reflect strong performance’
April 28, 2022HME News Staff
SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022.
The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic.
“Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...
REMSleep provides update on DeltaWaveÂ
March 29, 2022HME News Staff
TAMPA, Fla. – REMSleep has engaged a new third-party lab to redo testing for its DeltaWave as part of the 510k process for the nasal CPAP interface. The company says it has received a negative result on a cytotoxicity test due to incorrect procedures performed by a previous lab and has failed a re-test due to a faulty analysis by a testing company. “The failed test is not a result of management; we have run into a problem that we had not anticipated,” said CEO Tom Wood. “While...
ResMed survey outlines what’s keeping Americans up at nightÂ
March 15, 2022HME News Staff
SAN DIEGO – About 52% of Americans reported snoring or being told they snore, but only 33% are concerned about the associated health implications, according to ResMed’s 2022 Global Sleep Surveys.
“Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D., ResMed’s chief medical officer. “Sleep apnea is a serious health concern, but...